close

Fundraisings and IPOs

Date: 2011-04-05

Type of information: Fundraising

Company: PathoQuest (France)

Investors: Kurma Biofund (France)

Amount: €2 million

Funding type: series A financing round

Planned used:

Others:

PathoQuest has completed its first round of financing securing 2 M€ with the Kurma BioFund. This spin-off from the Pasteur Institute and the Ecole Nationale Vétérinaire d’Alfort (ENVA) has been founded in September 2010 by Professor Marc Eloit and Luc Boblet (PhD). PathoQuest has developed a proprietary expertise in metagenomics and pathogens identification by “Binning” or “De novo assembling” of high-throughput generated sequences. By discovering the etiology of major pathologies, in the field of infectious diseases and oncology, PathoQuest is committed to providing valuable new targets for diagnosis and vaccines to majors companies.The company is developing a dual-business model combining solely-owned R&D programs and a broad range of partnerships in discovery and services in pathogen identification.

Therapeutic area: Infectious diseases

Is general: Yes